sellWeak cluster of 2
Dennis Cho sold $3,684 of TWST
See Remarks at Twist Bioscience Corp. 92 shares at an average of $40.05, traded Mar 14, 2025, filed Mar 18, 2025.
Warning score
23Value
$3,684
92 shares
Holdings after
111,892
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$4k at market
- 0Share of holdings soldSold 0.1% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001214659-25-004495, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 14, 2025 | SOpen-market sale Common Stock | -92 | $40.05 | $3,684 | 111,892 | Mar 18, 2025 |
Related signals
Other insiders at Twist Bioscience Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 22Weak | sell | TWST Twist Bioscience Corp | Dennis Cho See Remarks | $58k | 348 | |
| 22Weak | sell | TWST Twist Bioscience Corp | Dennis Cho See Remarks | $51k | 412 | |
| 23Weak | sell 2 | TWST Twist Bioscience Corp | Dennis Cho See Remarks | $9,585 | 230 | |
| 23Weak | sell 2 | TWST Twist Bioscience Corp | Paula Green SVP of Human Resources | $12k | 291 | |
| 30Weak | sell 3 | TWST Twist Bioscience Corp | Dennis Cho See Remarks | $11k | 277 | |
| 36Weak | sell 3 | TWST Twist Bioscience Corp | Paula Green SVP of Human Resources | $38k | 918 | |
| 30Weak | sell 4 | TWST Twist Bioscience Corp | Dennis Cho See Remarks | $23k | 526 | |
| 44Moderate | sell 4 | TWST Twist Bioscience Corp | Patrick John Finn President and COO | $81k | 1,839 | |
| 35Weak | sell 4 | TWST Twist Bioscience Corp | Paula Green SVP of Human Resources | $27k | 618 | |
| 46Moderate | sell 4 | TWST Twist Bioscience Corp | Robert Chess director | $156k | 2,940 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.